Tarsus Pharmaceuticals, Inc. (TARS)
67.11
-1.13
(-1.66%)
USD |
NASDAQ |
Mar 19, 12:18
Tarsus Pharmaceuticals Total Liabilities (Quarterly) : 223.47M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Mirum Pharmaceuticals, Inc. | 528.12M |
| Summit Therapeutics, Inc. | 92.32M |
| Stoke Therapeutics, Inc. | 65.98M |
| Vir Biotechnology, Inc. | 259.65M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 566.90M |
| Shareholders Equity (Quarterly) | 343.43M |
| Debt to Equity Ratio | 0.2418 |
| Current Ratio | 3.853 |
| Net Debt Paydown Yield | -0.06% |